Alpha-linolenic acid metabolic enzymes

Alpha-linolenic acid (ALA) metabolic enzymes are a group of proteins, primarily desaturases and elongases, that catalyze the conversion of the essential omega-3 fatty acid ALA into long-chain polyunsaturated fatty acids (LC-PUFAs) like eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (PubMed 22138166). The primary enzymes involved are Delta-6 desaturase (FADS2), Delta-5 desaturase (FADS1), and fatty acid elongases 2 and 5 (ELOVL2, ELOVL5) (UniProt O60427, O95864, Q9NXB9, Q9NYD4). These enzymes are critical for maintaining cellular membrane composition and generating bioactive lipid mediators, such as resolvins and protectins, which possess potent anti-inflammatory properties (PubMed 27071938). Dysregulation or genetic variation in these enzymes, particularly within the FADS gene cluster, is strongly associated with metabolic syndrome, cardiovascular disease, and inflammatory conditions (PubMed 24332582). While ALA itself acts as a substrate, pharmacological research focuses on inhibiting these enzymes to modulate the balance of omega-3 and omega-6 fatty acids or using them as biomarkers for nutritional status. Challenges in targeting this pathway include the complex interplay between different fatty acid substrates and the potential for unintended systemic effects on lipid signaling (PubMed 30122554).

Other names

Alpha-linolenic acid metabolic pathway enzymesOmega-3 fatty acid desaturases and elongasesFADS-ELOVL pathway enzymesALA-to-DHA conversion enzymes

Substrate-level modulation of the omega-3 biosynthetic pathway and competitive or non-competitive inhibition of desaturase and elongase enzymatic activity.